| Zacks Company Profile for DexCom, Inc. (DXCM : NSDQ) |
|
|
| |
| • Company Description |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.
Number of Employees: 10,300 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $84.10 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 3,590,658 shares |
| Shares Outstanding: 392.11 (millions) |
| Market Capitalization: $32,976.24 (millions) |
| Beta: 1.44 |
| 52 Week High: $113.28 |
| 52 Week Low: $57.52 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
3.81% |
-1.40% |
| 12 Week |
18.82% |
3.49% |
| Year To Date |
8.14% |
1.00% |
|
|
|
|
| |
|
|
| |
| • General Corporate Information |
Officers
Kevin R. Sayer - Chairman of the Board of Directors; President and
Jereme M. Sylvain - Executive Vice President and Chief Financial Offic
Mark G. Foletta - Lead Independent Director
Steven R. Altman - Director
Nicholas Augustinos - Director
|
|
Peer Information
DexCom, Inc. (ABMD)
DexCom, Inc. (DMDS)
DexCom, Inc. (CPWY.)
DexCom, Inc. (EQUR)
DexCom, Inc. (ECIA)
DexCom, Inc. (FMS)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 252131107
SIC: 3841
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 07/30/25
|
|
Share - Related Items
Shares Outstanding: 392.11
Most Recent Split Date: 6.00 (4.00:1)
Beta: 1.44
Market Capitalization: $32,976.24 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $0.57 |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $2.03 |
Payout Ratio: 0.00 |
| Number of Estimates in the Fiscal Year Consensus: 11.00 |
Change In Payout Ratio: 0.00 |
| Estmated Long-Term EPS Growth Rate: 23.10% |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 07/30/25 |
|
|
|
| |
